annual D&A:
$1.23M+$348.00K(+39.68%)Summary
- As of today (May 24, 2025), TARS annual depreciation & amortization is $1.23 million, with the most recent change of +$348.00 thousand (+39.68%) on December 31, 2024.
- During the last 3 years, TARS annual D&A has risen by +$913.00 thousand (+292.63%).
- TARS annual D&A is now at all-time high.
Performance
TARS Depreciation and amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly D&A:
$460.00K+$28.00K(+6.48%)Summary
- As of today (May 24, 2025), TARS quarterly depreciation & amortization is $460.00 thousand, with the most recent change of +$28.00 thousand (+6.48%) on March 31, 2025.
- Over the past year, TARS quarterly D&A has increased by +$190.00 thousand (+70.37%).
- TARS quarterly D&A is now at all-time high.
Performance
TARS quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM D&A:
$1.42M+$190.00K(+15.51%)Summary
- As of today (May 24, 2025), TARS TTM depreciation & amortization is $1.42 million, with the most recent change of +$190.00 thousand (+15.51%) on March 31, 2025.
- Over the past year, TARS TTM D&A has increased by +$372.00 thousand (+35.67%).
- TARS TTM D&A is now at all-time high.
Performance
TARS TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TARS Depreciation and amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +39.7% | +70.4% | +35.7% |
| 3 y3 years | +292.6% | +1022.0% | +389.6% |
| 5 y5 years | +3210.8% | +2966.7% | +9333.3% |
TARS Depreciation and amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +292.6% | at high | +1022.0% | at high | +452.7% |
| 5 y | 5-year | at high | +3210.8% | at high | +2966.7% | at high | +9333.3% |
| alltime | all time | at high | >+9999.0% | at high | +2966.7% | at high | +9333.3% |
TARS Depreciation and amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $460.00K(+6.5%) | $1.42M(+15.5%) |
| Dec 2024 | $1.23M(+39.7%) | $432.00K(+52.1%) | $1.23M(+7.5%) |
| Sep 2024 | - | $284.00K(+18.8%) | $1.14M(+3.6%) |
| Jun 2024 | - | $239.00K(-11.5%) | $1.10M(+5.5%) |
| Mar 2024 | - | $270.00K(-22.2%) | $1.04M(+18.9%) |
| Dec 2023 | $877.00K(+169.0%) | $347.00K(+42.2%) | $877.00K(+39.4%) |
| Sep 2023 | - | $244.00K(+34.1%) | $629.00K(+31.3%) |
| Jun 2023 | - | $182.00K(+75.0%) | $479.00K(+23.1%) |
| Mar 2023 | - | $104.00K(+5.1%) | $389.00K(+19.3%) |
| Dec 2022 | $326.00K | $99.00K(+5.3%) | $326.00K(+22.1%) |
| Sep 2022 | - | $94.00K(+2.2%) | $267.00K(+4.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | $92.00K(+124.4%) | $256.00K(-11.4%) |
| Mar 2022 | - | $41.00K(+2.5%) | $289.00K(-7.4%) |
| Dec 2021 | $312.00K(+225.0%) | $40.00K(-51.8%) | $312.00K(0.0%) |
| Sep 2021 | - | $83.00K(-33.6%) | $312.00K(+23.3%) |
| Jun 2021 | - | $125.00K(+95.3%) | $253.00K(+74.5%) |
| Mar 2021 | - | $64.00K(+60.0%) | $145.00K(+51.0%) |
| Dec 2020 | $96.00K(+159.5%) | $40.00K(+66.7%) | $96.00K(+71.4%) |
| Sep 2020 | - | $24.00K(+41.2%) | $56.00K(+75.0%) |
| Jun 2020 | - | $17.00K(+13.3%) | $32.00K(+113.3%) |
| Mar 2020 | - | $15.00K | $15.00K |
| Dec 2019 | $37.00K(+3600.0%) | - | - |
| Dec 2018 | $1000.00 | - | - |
FAQ
- What is Tarsus Pharmaceuticals annual depreciation & amortization?
- What is the all time high annual D&A for Tarsus Pharmaceuticals?
- What is Tarsus Pharmaceuticals annual D&A year-on-year change?
- What is Tarsus Pharmaceuticals quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Tarsus Pharmaceuticals?
- What is Tarsus Pharmaceuticals quarterly D&A year-on-year change?
- What is Tarsus Pharmaceuticals TTM depreciation & amortization?
- What is the all time high TTM D&A for Tarsus Pharmaceuticals?
- What is Tarsus Pharmaceuticals TTM D&A year-on-year change?
What is Tarsus Pharmaceuticals annual depreciation & amortization?
The current annual D&A of TARS is $1.23M
What is the all time high annual D&A for Tarsus Pharmaceuticals?
Tarsus Pharmaceuticals all-time high annual depreciation & amortization is $1.23M
What is Tarsus Pharmaceuticals annual D&A year-on-year change?
Over the past year, TARS annual depreciation & amortization has changed by +$348.00K (+39.68%)
What is Tarsus Pharmaceuticals quarterly depreciation & amortization?
The current quarterly D&A of TARS is $460.00K
What is the all time high quarterly D&A for Tarsus Pharmaceuticals?
Tarsus Pharmaceuticals all-time high quarterly depreciation & amortization is $460.00K
What is Tarsus Pharmaceuticals quarterly D&A year-on-year change?
Over the past year, TARS quarterly depreciation & amortization has changed by +$190.00K (+70.37%)
What is Tarsus Pharmaceuticals TTM depreciation & amortization?
The current TTM D&A of TARS is $1.42M
What is the all time high TTM D&A for Tarsus Pharmaceuticals?
Tarsus Pharmaceuticals all-time high TTM depreciation & amortization is $1.42M
What is Tarsus Pharmaceuticals TTM D&A year-on-year change?
Over the past year, TARS TTM depreciation & amortization has changed by +$372.00K (+35.67%)